Vioxx. The drug was reported to display risks due to its inhibitor known as COX-2 which is an anti inflammatory drug. Patients who used the drug were prone to the reception of cardiovascular diseases. Research indicated that when patients limited their use of the drug

they faced a lower risk of receiving cardiovascular diseases. The wall street journal is one of the articles that played a significant role in the providing their view on the Merck vioxx case. The article implicated the company stating that they were aware of the reaction of the drug on patients. Despite this